Qulipta 30 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FZY06
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,202
Award facts
- Contract value 100% obligated
- $6,201.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Qulipta 30 mg tablets (30-count units). This $6,201.60 firm fixed-price delivery order was issued on September 23, 2025, with an ultimate completion date of September 24, 2025. The award was made without a set-aside designation, allowing the contractor to compete on an unrestricted basis. Performance will take place at the vendor's facility in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the Defense Logistics Agency valued at approximately $500 million and valid through November 2026. The underlying IDC enables the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical products supporting military health facility medical supply needs worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and specialized medications to Department of Defense healthcare sites. The company's robust portfolio of federal contract awards demonstrates its capability to reliably distribute diverse pharmaceutical products ranging from routine medications to specialized oncology and immunology treatments.
Quick answers
Who was awarded contract SPE2DB25FZY06?
SPE2DB25FZY06 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FZY06 worth?
The government has obligated $6,202 on SPE2DB25FZY06.
Is contract SPE2DB25FZY06 an order under another contract?
Yes. SPE2DB25FZY06 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZY06 competed?
The extent of competition for SPE2DB25FZY06 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award